Novel aspects of the endocrinology of the menstrual cycle
- PMID: 24745832
- DOI: 10.1016/j.rbmo.2014.02.003
Novel aspects of the endocrinology of the menstrual cycle
Abstract
Ovarian control of gonadotrophin secretion is normally achieved via the feedback mechanisms mediated by oestradiol and progesterone. Evidence has been provided that nonsteroidal substances, such as inhibin A and B, participate in the negative feedback control of FSH secretion. Another nonsteroidal ovarian substance is gonadotrophin surge-attenuating factor (GnSAF), the activity of which is particularly evident in women undergoing ovulation induction. Accumulating evidence has suggested that GnSAF plays a physiological role during the menstrual cycle. In particular, this factor antagonizes the sensitizing effect of oestradiol on the pituitary response to gonadotrophin-releasing hormone during the follicular phase of the cycle. A hypothesis has been developed that, in the late follicular phase, the activity of GnSAF is reduced and this facilitates the sensitizing effect of oestradiol on the pituitary, thus enforcing the massive discharge of gonadotrophins at the midcycle LH surge. The interaction of oestradiol, progesterone and GnSAF on the hypothalamic-pituitary system provides a novel approach to explain the mechanisms which control LH secretion during the normal menstrual cycle. The ovarian control of gonadotrophin secretion during the normal menstrual cycle is achieved via negative and positive feedback mechanisms. The steroids oestradiol and progesterone are the main regulators; however, nonsteroidal substances, such as inhibin A and inhibn B, also participate. Accumulating evidence has demonstrated that another nonsteroidal ovarian substance, gonadotrophin surge-attenuating factor (GnSAF), plays a key role in the control of LH secretion during the follicular phase and at midcycle, providing thus a novel aspect in the ovarian control of gonadotrophin secretion during the human menstrual cycle. The ovarian control of gonadotrophin secretion during the normal menstrual cycle is achieved via negative and positive feedback mechanisms. The steroids oestradiol and progesterone are the main regulators; however, nonsteroidal substances, such as inhibin A and inhibn B, also participate. Accumulating evidence has demonstrated that another nonsteroidal ovarian substance, gonadotrophin surge-attenuating factor (GnSAF), plays a key role in the control of LH secretion during the follicular phase and at midcycle, providing thus a novel aspect in the ovarian control of gonadotrophin secretion during the human menstrual cycle.
Keywords: GnSAF; gonadotrophins; inhibin; oestradiol; ovary; progesterone.
Copyright © 2014 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
Ovarian feedback, mechanism of action and possible clinical implications.Hum Reprod Update. 2006 Sep-Oct;12(5):557-71. doi: 10.1093/humupd/dml020. Epub 2006 May 3. Hum Reprod Update. 2006. PMID: 16672246 Review.
-
The effects of steroidal and non-steroidal ovarian hormones on pituitary responsiveness to gonadotrophin surge-attenuating factor.J Endocrinol. 1996 Sep;150(3):413-22. doi: 10.1677/joe.0.1500413. J Endocrinol. 1996. PMID: 8882160
-
Ovarian gonadotrophin surge-attenuating factor (GnSAF): where are we after 20 years of research?Reproduction. 2003 Dec;126(6):689-99. doi: 10.1530/rep.0.1260689. Reproduction. 2003. PMID: 14748688 Review.
-
Modulatory effect of the ovary on LH secretion.Ann N Y Acad Sci. 2003 Nov;997:35-41. doi: 10.1196/annals.1290.004. Ann N Y Acad Sci. 2003. PMID: 14644807 Review.
-
Effect of follicle stimulating hormone or human chorionic gonadotrophin treatment on the production of gonadotrophin surge attenuating factor (GnSAF) during the luteal phase of the human menstrual cycle.Clin Endocrinol (Oxf). 1996 Feb;44(2):169-75. doi: 10.1046/j.1365-2265.1996.589411.x. Clin Endocrinol (Oxf). 1996. PMID: 8849571 Clinical Trial.
Cited by
-
Role of insulin and insulin resistance in androgen excess disorders.World J Diabetes. 2021 May 15;12(5):616-629. doi: 10.4239/wjd.v12.i5.616. World J Diabetes. 2021. PMID: 33995849 Free PMC article. Review.
-
Regenerative Medicine Approaches in Bioengineering Female Reproductive Tissues.Reprod Sci. 2021 Jun;28(6):1573-1595. doi: 10.1007/s43032-021-00548-9. Epub 2021 Apr 20. Reprod Sci. 2021. PMID: 33877644 Review.
-
COVID-19 and Female Fertility: An Observational Prospective Multicenter Cohort Study: Upholding Reproductive Rights in Emergency Circumstances.Diagnostics (Basel). 2024 Sep 24;14(19):2118. doi: 10.3390/diagnostics14192118. Diagnostics (Basel). 2024. PMID: 39410522 Free PMC article.
-
What We Have Learned from Animal Models to Understand the Etiology and Pathology of Endometrioma-Related Infertility.Biomedicines. 2022 Jun 23;10(7):1483. doi: 10.3390/biomedicines10071483. Biomedicines. 2022. PMID: 35884788 Free PMC article. Review.
-
Molecular Mechanisms of Action of FSH.Front Endocrinol (Lausanne). 2019 May 14;10:305. doi: 10.3389/fendo.2019.00305. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31139153 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources